3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
103
Phase NA
71
Phase 1/2
56
Phase 2
49
Phase 3
15
Phase EARLY_PHASE1
9
Phase 2/3
4
Phase 4
2
Status
Recruiting
2
Withdrawn
1
Not yet recruiting
1
Sponsor Class
OTHER
4
Study Type
Interventional
4
Sponsor
Cancer Type
Gastrointestinal
21
Tumor-Agnostic
18
Other hematologic neoplasm
15
Lymphoid
14
Genitourinary
11
Thoracic
10
Plasma cell
7
Dermatologic
6
CNS
6
Gynecologic
5
Myeloid
4
Head & Neck
4
Breast
4
Sarcoma
3
Endocrine
3
Classical hematology
2
Other
1
NET
1
Conditions
Head and Neck Neoplasms
32
Squamous Cell Carcinoma of Head and Neck
24
Nasopharyngeal Carcinoma
10
Mouth Neoplasms
10
Thyroid Neoplasms
9
Oropharyngeal Neoplasms
9
Laryngeal Neoplasms
8
Ovarian Neoplasms
5
Lung Neoplasms
5
Hypopharyngeal Neoplasms
5
Colorectal Neoplasms
5
Neoplasms
4
Neoplasm Metastasis
4
Melanoma
4
Carcinoma, Squamous Cell
4
Carcinoma
4
Thyroid Carcinoma, Anaplastic
3
Thyroid Cancer, Papillary
3
Recurrence
3
Neoplasms, Squamous Cell
3
Nasopharyngeal Neoplasms
3
Hematologic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Uterine Cervical Neoplasms
2
Urinary Bladder Neoplasms
2
Stomatitis
2
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Parathyroid Neoplasms
2
Interventions
trametinib
1
pertuzumab
1
dabrafenib
1
cobimetinib
1
Vemurafenib
1
Trastuzumab
1
Thyroxine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
4 trials
Recent
Start date
Enrollment
Phase 2/3
×
Neoplasms
×
Head & Neck
×
Clear all
NCT07440290
2026-02-27
DETERMINE
Cancer Research UK
Phase 2/3
Not yet recruiting
30 enrolled
NCT05786716
2025-12-02
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled
NCT05768178
2025-11-24
DETERMINE
Cancer Research UK
Phase 2/3
Recruiting
30 enrolled
NCT02548715
2022-07-13
LSHT
University of Alberta
Phase 2/3
Withdrawn